Haemodynamic effects of intravenous nimodipine following aneurysmal subarachnoid haemorrhage: Implications for monitoring

Anaesthesia

Volumn 52, Issue 5, 1997, Pages 489-491

  Radhakrishnan, D ^a   Menon, D K ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Pharmacology; nimodipine; Surgery; neurological

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; HYPERTENSIVE AGENT; INOTROPIC AGENT; NIMODIPINE;

ADULT; AGED; ARTERY CATHETERIZATION; ARTICLE; BRAIN ARTERY ANEURYSM; CLINICAL ARTICLE; CLINICAL TRIAL; HEMODILUTION; HEMODYNAMICS; HUMAN; HYPERVOLEMIA; HYPOTENSION; NEUROLOGIC DISEASE; PATIENT MONITORING; POSTOPERATIVE CARE; PULMONARY ARTERY; SUBARACHNOID HEMORRHAGE; VASODILATATION;

EID: 0030908624     PISSN: 00032409     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2044.1997.112-az0105.x     Document Type: Article

References (12)

1. Kassell NF, Torner JC, Haley EC, Jane JA, Adams HP, Kongable GL and participants. The International Cooperative Study on the timing of Aneurysm Surgery, Part 1: Overall management results. Journal of Neurosurgery 1990; 73: 18-36.
2. Kassell NF, Torner JC, Jane JA, Haley EC, Adams HP and participants. The International Cooperative Study on the timing of Aneurysm Surgery, Part 2: Surgical results. Journal of Neurosurgery 1990; 73: 37-47.
3. Pickard JD, Murray GD, Illingworth R, et al. Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage. British aneurysm nimodipine trial. British Medical Journal 1989; 298: 636-42.
4. Ramsch KD, Ahr G, Tettenborn D, Auer LM. Overview on pharmacokinetics of nimodipine in healthy volunteers and in patients with subarachnoid haemorrhage. Neurochirurgia 1985; 28.
5. Martin N, Khanna R, Rodts G. The intensive care management of patients with subarachnoid hemorrhage. In: Andrews BT, ed. Neurosurgical Intensive Care, International Edition. USA: McGraw-Hill, 1993: 291-310.
6. Kassell NF, Peerless SJ, Durward QJ, Beck DW, Drake CG, Adams HP. Treatment of ischaemic deficits from vasospasm with intravascular volume expansion and induced arterial hypertension. Neurosurgery 1982; 11: 337-43.
7. Origitano TC, Wascher TM, Reichman OH, Anderson DE. Sustained increased cerebral blood flow with prophylactic hypervolaemic haemodilution ("Triple-H" Therapy) after subarachnoid haemorrhage. Neurosurgery 1990; 27: 729-38.
8. Hunt WE, Hess RM. Surgical risk as related to time of intervention in the repair of intracranial aneurysms. Journal of Neurosurgery 1968; 28: 14-20.
9. Lindegaard KF, Nornes H, Bakke SJ, Sorteberg W, Nakstad P. Cerebral vasospasm after subarachnoid haemorhage by means of transcranial Doppler ultrasound. Acta Neurochirurgica (Wien) 1988; 24: 81-4.
10. Levy ML, Giannotta SL. Cardiac performance indices during hypervolaemic therapy for cerebral vasospasm. Journal of Neurosurgery 1991; 75: 27-31.
11. Whitfield PC, Moss H, O'Hare D, Smelewski P, Pickard JD, Kirkpatrick PJ. An audit of aneurysmal subarachnoid haemorrhage - Earlier resuscitation and surgery reduces in patient stay and deaths from rebleeding. Journal of Neurology, Neurosurgery and Psychiatry 1996; 60: 301-6.
12. Marion DW, Segal R, Thompson ME. SAH and the heart. Neurosurgery 1986; 18: 101-8.